Asymchem Laboratories (Tianjin) Co., Ltd.

HKEX
6821
Stock
Yield per half year: +28.02%
Dividend yield: 8.03%
Sector: Healthcare

Company Analysis Asymchem Laboratories (Tianjin) Co., Ltd.

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Dividends (8.03%) are higher than the sector average (5.6%).
  • The stock's return over the last year (71.96%) is higher than the sector average (13.79%).
  • The company's current efficiency (ROE=5.53%) is higher than the sector average (ROE=4.24%)

Disadvantages

  • Price (69.9 HK$) is higher than fair price (31.52 HK$)
  • Current debt level 0.6983% has increased over 5 years from 0%.

Similar companies

Hansoh Pharmaceutical Group Company Limited

Hangzhou Tigermed Consulting Co., Ltd

CSPC Pharmaceutical Group Limited

WuXi AppTec Co., Ltd.

2. Share price and performance

2.1. Share price

2.3. Market efficiency

Asymchem Laboratories (Tianjin) Co., Ltd. Healthcare Index
7 days -11.6% 21.7% -1.5%
90 days 65.6% -4.3% -0.7%
1 year 72% 13.8% 30.5%

6821 vs Sector: Asymchem Laboratories (Tianjin) Co., Ltd. has outperformed the "Healthcare" sector by 58.16% over the past year.

6821 vs Market: Asymchem Laboratories (Tianjin) Co., Ltd. has outperformed the market by 41.44% over the past year.

Slightly volatile price: 6821 is more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical deviations of about +/- 5-15% per week.

Long period: 6821 with weekly volatility of 1.38% over the past year.

3. Summary of the report

3.1. General

P/E: 18.75
P/S: 3.07

3.2. Revenue

EPS 2.58
ROE 5.53%
ROA 4.86%
ROIC 0%
Ebitda margin 52.14%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (69.9 HK$) is higher than the fair price (31.52 HK$).

Price is higher than fair: The current price (69.9 HK$) is 54.9% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (18.75) is lower than that of the sector as a whole (31.87).

P/E vs Market: The company's P/E (18.75) is lower than that of the market as a whole (44.35).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (1.06) is lower than that of the sector as a whole (2.54).

P/BV vs Market: The company's P/BV (1.06) is lower than that of the market as a whole (1.59).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (3.07) is lower than that of the sector as a whole (6.25).

P/S vs Market: The company's P/S indicator (3.07) is higher than that of the market as a whole (2.64).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (10.74) is higher than that of the sector as a whole (2.91).

EV/Ebitda vs Market: The company's EV/Ebitda (10.74) is higher than that of the market as a whole (9.93).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 6.37% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (6.37%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-25.07%).

5.4. ROE

ROE vs Sector: The company's ROE (5.53%) is higher than that of the sector as a whole (4.24%).

ROE vs Market: The company's ROE (5.53%) is higher than that of the market as a whole (2.87%).

5.5. ROA

ROA vs Sector: The company's ROA (4.86%) is higher than that of the sector as a whole (3.29%).

ROA vs Market: The company's ROA (4.86%) is higher than that of the market as a whole (3.12%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).

ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (20.88%).

6. Finance

6.1. Assets and debt

Debt level: (0.6983%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 0% to 0.6983%.

Debt Covering: The debt is covered by 14.19% from net profit.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

High yield: The dividend yield of the company 8.03% is higher than the average for the sector '5.6%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 8.03% has been steadily paid over the past 7 years, DSI=0.88.

Weak dividend growth: The company's dividend yield 8.03% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (67.65%) are at a comfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

No insider transactions have been recorded yet

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Asymchem Laboratories (Tianjin) Co., Ltd.

9.3. Comments